Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 29, 2020 - Issue 8
Submit an article Journal homepage
916
Views
7
CrossRef citations to date
0
Altmetric
Review

Hypoxia-inducible factor prolyl hydroxylase inhibitors: a paradigm shift for treatment of anemia in chronic kidney disease?

Ernane SouzaDepartment of Clinical Pharmacy, University of Michigan, Ann Arbor, MI, USACorrespondence[email protected]
View further author information
,
Katherine H. ChoDepartment of Clinical Pharmacy, University of Michigan, Ann Arbor, MI, USAView further author information
,
Shelby T. HarrisDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USAView further author information
,
Naomi R. FlindtDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USAView further author information
,
Richard K. WattDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USAView further author information
&
Amy Barton PaiDepartment of Clinical Pharmacy, University of Michigan, Ann Arbor, MI, USAView further author information
Pages 831-844 | Received 20 Mar 2020, Accepted 29 May 2020, Published online: 16 Jun 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hiroki Takano, Akiko Mizuno-Yasuhira, Jun-ichi Yamaguchi & Hiromi Endo. (2022) Elucidation of clearance mechanism of TP0463518, a novel hypoxia-inducible factor prolyl hydroxylase inhibitor: does a species difference in excretion routes exist between humans and animals?. Xenobiotica 52:7, pages 729-741.
Read now

Articles from other publishers (6)

Xuejie Zhang, Ruoyu Jia, Zhifang Zheng, Luhua Jiang, Yizhou Xu, Ashok Raj & Dong Sun. (2023) Effect of roxadustat on iron metabolism in patients with peritoneal dialysis: a real-world 24-week study. European Journal of Medical Research 28:1.
Crossref
Zuo-Lin Li, Bin WangYi WenQiu-Li WuLin-Li LvBi-Cheng Liu. (2022) Disturbance of Hypoxia Response and Its Implications in Kidney Diseases. Antioxidants & Redox Signaling 37:13-15, pages 936-955.
Crossref
Д.Ш. Джалилова & О.В. Макарова. (2021) HIF-опосредованные механизмы взаимосвязи устойчивости к гипоксии и опухолевого роста. Биохимия 86:10, pages 1403-1422.
Crossref
Dzhuliia Sh. Dzhalilova & Olga V. Makarova. (2021) HIF-Dependent Mechanisms of Relationship between Hypoxia Tolerance and Tumor Development. Biochemistry (Moscow) 86:10, pages 1163-1180.
Crossref
Mary Frances McMullin. (2021) Genetic Background of Congenital Erythrocytosis. Genes 12:8, pages 1151.
Crossref
Kuo-Hua Lee, Yang Ho & Der-Cherng Tarng. (2021) Iron Therapy in Chronic Kidney Disease: Days of Future Past. International Journal of Molecular Sciences 22:3, pages 1008.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.